Sfoglia per AUTORE
BASSAN R
Collezione AO Cuneo

  

Items : 12

Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial. in Blood advances / Blood Adv. 2023 Aug 22;7(16):4448-4461. doi: 10.1182/bloodadvances.2022009596.

2023
AO Cuneo
AOU Città della Salute di Torino

Vitale A; Trappolini S; Guarini A; Latte G; Di Bartolomeo P; Cassibba V; Candoni A; Bonifacio M; De Fabritiis P; Bocchia M; Fracchiolla N; Mattei D; Martinelli G; Mauro E; Zappasodi P; Borlenghi E; Marbello L; Audisio E; Scattolin AM; De Propris MS; Elia L; Messina M; Paoloni F; Spinelli O; Santoro A; Della Starza I; Bassan R; Chiaretti S; Fazi P; et alii...

Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06. in Haematologica / Haematologica. 2021 Oct 1;106(10):2578-2587. doi: 10.3324/haematol.2020.252825.

2021
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Rambaldi A; Spinelli O; Pavoni C; Bassan R; Cortelezzi A; Falini B; Todisco E; Bernardi M; Campiotti L; Ciceri F; Mattei D; Corradini P; Scattolin AM; Cavattoni I; Tajana M; Ferrero D; Audisio E; Terruzzi E; De Paoli L; Cattaneo C; Borlenghi E; Mannelli F; Gianfaldoni G; Grassi A; Delaini F; Oldani E; Intermesoli T; Michelato A; Elidi L; et alii...

Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913. in Haematologica / Haematologica. 2021 Jun 1;106(6):1559-1568. doi: 10.3324/haematol.2020.247973.

2021
AOU Città della Salute di Torino
AO Cuneo

Vitale A; Cattaneo C; Mattei D; Fracchiolla N; Cerrano M; Cairoli R; Candoni A; Papayannidis C; De Fabritiis P; Di Raimondo F; Capria S; Apicella V; Spinelli O; Santoro A; Pierini V; Puzzolo MC; Lauretti A; Canichella M; La Starza R; Albertini Petroni G; Elia L; Ansuinelli M; Taherinasab A; Cavalli M; Cafforio L; Piciocchi A; Della Starza I; Messina M; Chiaretti S; et alii...

Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18-65 years: NILG ALL 10/07. in Blood cancer journal / Blood Cancer J. 2020 Nov 13;10(11):119. doi: 10.1038/s41408-020-00383-2.

2020
AO Cuneo
AOU Città della Salute di Torino
AOU Alessandria

Rambaldi A; Masciulli A; Oldani E; Depaoli L; Bernardi M; Scattolin AM; Fracchiolla N; Ciceri F; Cortelezzi A; Mattei D; Romani C; Cavattoni I; Fumagalli M; Borlenghi E; Cortelazzo S; Audisio E; Marmont F; Cattaneo C; Tosi M; Spinelli O; Intermesoli T; Pavoni C; Bassan R;

High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG). in Cancers / Cancers (Basel). 2020 Aug 11;12(8):2242. doi: 10.3390/cancers12082242.

2020
AO Cuneo
AOU Città della Salute di Torino
AOU Alessandria

Spinelli O; Rambaldi A; Bassan R; Fracchiolla N; Corradini P; Campiotti L; Todisco E; Scattolin A; Ciceri F; Tajana M; Mattei D; Cavattoni I; Borlenghi E; De Paoli L; Audisio E; Terruzzi E; Gianfaldoni G; Oldani E; Lussana F; Intermesoli T; Caprioli C; Stefanoni P; Buklijas K; Elidi L; Michelato A; Salmoiraghi S; Pavoni C; Zanghì P; Cavagna R; et alii...

Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML. in Blood advances / Blood Adv. 2019 Apr 9;3(7):1103-1117. doi: 10.1182/bloodadvances.2018026625.

2019
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Falini B; Bosi A; Cortelazzo S; Audisio E; Oldani E; Spinelli O; Zanghì P; Ferrero D; Cortelezzi A; Corradini P; Campiotti L; Scattolin AM; Todisco E; Bernardi M; Borlenghi E; Ciceri F; Cattaneo C; De Paoli L; Cavattoni I; Mattei D; Terruzzi E; Marmont F; Gianfaldoni G; Boschini C; Pavoni C; Masciulli A; Bassan R; Intermesoli T; Pogliani EM; et alii...

Molecular prolife by next generation sequencing of acute myeloid leukemia with normal karyotype: Clinical results from the prospective trial 02/06 of the Northern Italy leukemia group (NILG) in Haematologica

2018
AO Cuneo
AOU Alessandria

Spinelli O; Salmoiraghi S; Zanghi P; Cavagna R; Michelato A; Buklijas K; Zannino L; Intermesoli T; Lussana F; Delaini F; Oldani E; Caprioli C; Stefanoni P; Gianfaldoni G; Marmont F; Ferrero D; Terruzzi E; De Paoli L; Rossi G; Borlenghi E; Cavattoni I; Tajana M; Scattolin AM; Mattei D; Corradini P; Campiotti L; Ciceri F; Bernardi M; Todisco E; et alii...

New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment? in Expert opinion on biological therapy / Expert Opin Biol Ther. 2017 Jul;17(7):821-836. doi: 10.1080/14712598.2017.1324567. Epub 2017 May 22.

2017
AO Cuneo
AOU Città della Salute di Torino

Bruno B; Bonifazi F; Rambaldi A; Baccarani M; Fanin R; Ciceri F; Corradini P; Bassan R; Zaja F; Risitano A; Volpetti S; Festuccia M; Greco R; Peccatori J; Mordini N; Maino E; Mussetti A; Sarina B; Montefusco V; Patriarca F; Giaccone L; Onida F; Castagna L;

Achieving Molecular Remission before Allogeneic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Impact on Relapse and Long-Term Outcome. in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation / Biol Blood Marrow Transplant. 2016 Nov;22(11):1983-1987. doi: 10.1016/j.bbmt.2016.07.021. Epub 2016

2016
AOU Città della Salute di Torino
AO Cuneo

Rambaldi A; Bassan R; Romani C; Borlenghi E; Terruzzi E; Mattei D; Ciceri F; Mannelli F; Scattolin AM; Cortelezzi A; Cavattoni IM; Angelucci E; Raimondi R; Cattaneo C; Audisio E; Grassi A; Parolini M; Tosi M; Spinelli O; Oldani E; Masciulli A; Boschini C; Gianni F; Intermesoli T; Lussana F;

Sequential high-dose cytarabine plus idarubicin improves remission rate and survival duration in adult acute myelogenous leukemia (AML): Randomized trial of the Northern Italy leukemia group (NILG) in Haematologica

2016
AOU Alessandria
AO Ordine Mauriziano
AO Cuneo

Bassan R; Intermesoli T; Masciulli A; Boschini C; Gianfaldoni G; Marmont F; Cavattoni I; Mattei D; Terruzzi E; De Paoli L; Rossi G; Borlenghi E; Ciceri F; Bernardi M; Scattolin AM; Todisco E; Campiotti L; Corradini P; Cortelezzi A; Tajana M; Ferrero D; Cignetti A; Marfisi RM; Delaini F; Zanghì P; Oldani E; Spinelli O; Audisio E; Cortelazzo S; et alii...

Randomized trial of radiation-free central nervous system prophylaxis comparing intrathecal triple therapy with liposomal cytarabine in acute lymphoblastic leukemia. in Haematologica / Haematologica. 2015 Jun;100(6):786-93. doi: 10.3324/haematol.2014.123273. Epub 2015 Mar 6.

2015
AO Cuneo
AOU Città della Salute di Torino

Rambaldi A; Marfisi RM; Oldani E; Gallamini A; Cortelazzo S; Fumagalli M; Marmont F; Borlenghi E; Parolini M; Tosi M; Spinelli O; Scattolin AM; Corti C; Cortelezzi A; Romani C; Mattei D; Cassibba V; Rossi G; Pogliani EM; Audisio E; Intermesoli T; Masciulli A; Bassan R;

Different molecular levels of post-induction minimal residual disease may predict hematopoietic stem cell transplantation outcome in adult Philadelphia-negative acute lymphoblastic leukemia. in Blood cancer journal / Blood Cancer J. 2014 Jul 11;4(7):e225. doi: 10.1038/bcj.2014.48.

2014
AO Cuneo

Mattei D; Rambaldi A; Audisio E; Gianfaldoni G; Ciceri F; Cortelezzi A; Scattolin AM; Romani C; Cassibba V; Di Bona E; Borlenghi E; Intermesoli T; Pogliani EM; Peruta B; Tosi M; Oldani E; Bassan R; Spinelli O;